SecBot SecBot
Insider Cluster (2 insiders) ·Filed May 19, 2026

PTCT

PTC THERAPEUTICS, INC.
NEUTRAL
Impact 2/10
Horizondays Processed6mo ago
Insider cluster: 2 insiders, $219K total
Actionable Insight • Neutral

This cluster is noise. The post-earnings window and strong fundamentals (raised guidance, Sephience momentum) continue to support PTCT. Monitor if larger C-suite sales emerge in the next 30 days, but this filing alone carries no bearish conviction.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$71.02
T+0 close · May 19, 2026 · via day close
Latest settled
+0.96%
T+60 · $71.70
Vs SPY
−4.05%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 20 $71.02entry
  2. T+1 · 6mo ago −1.73%α −1.93% · $69.79
  3. T+5 · 6mo ago +0.04%α −1.76% · $71.05
  4. T+20 · 5mo ago +11.21%α +10.47% · $78.98
  5. T+60 · 3mo ago +0.96%α −4.05% · $71.70

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two insiders at PTC Therapeutics sold a combined $220K of stock shortly after a strong Q1 earnings beat and raised guidance. CEO Matthew Klein's sale is a routine tax-withholding grant (12,500 shares awarded, none sold), while General Counsel Mark Boulding exercised options and sold a portion of the resulting shares. The total dollar value is only ~0.004% of market cap, immaterial and likely driven by standard post-earnings window openings and tax-planning, not a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$219.4K
Insiders
2

Key Facts

  • CEO Matthew Klein: 12,500 shares granted via award ($0) on May 13; then sold 679 shares at $73.06 ($50K) on May 14, a small tax-coverage disposition.
  • General Counsel Mark Boulding: exercised 5,624 options (2,812 at $0, 2,812 at $25.69) on May 15; sold 2,356 shares ($170K) open-market.
  • Total insider sales value ~$220K, representing ~0.004% of PTCT's $5.8B market cap.
  • Just 12 days prior, PTCT reported Q1 2026 product revenue of $226M (up 47% YoY) and raised full-year product revenue guidance to $750-$850M.
  • The insider cluster occurred after a strong earnings report and within an open trading window, consistent with routine post-earnings option exercises and tax sales.

Financial Impact

Insider sales of ~$220K, negligible relative to $5.8B market cap

dilutioninsider-ownership

Risk Factors

  • Translarna and Emflaza revenue continue to decline due to generic erosion and regulatory headwinds.
  • Any future insider sales above ~$2M (0.03% of market cap) would be more notable, especially if from CEO or CFO.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
68% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PTCT-1779225646329

Track record

29 reports on PTCT

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +19.01% at T+60 after the Apr 28, 2026 report. 5 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $62.09 Now $60.97 −1.80% settles Nov 17
  2. Nov 16, 2026today 144 Neutral 2/10 Entry $62.10 Now $60.97 −1.82% settles Nov 17
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $63.45 Now $60.97 −3.91% settles Nov 17
  4. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $64.14 to $64.91 Now $60.97 −4.94% ▲ +1.20% −0.12% vs SPY
  5. Nov 3, 202613d ago 8-K Neutral 3/10 Entry $68.12 to $68.97 Now $60.97 −10.50% ▲ +1.25% −0.40% vs SPY
  6. Nov 3, 202613d ago Press Release Neutral 3/10 Entry $68.12 to $68.97 Now $60.97 −10.50% ▲ +1.25% −0.40% vs SPY
  7. Nov 2, 202614d ago Institutional Cluster Bearish 4/10 Entry $68.12 to $68.97 Now $60.97 +10.50% ▼ −1.25% +0.40% vs SPY
  8. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $59.97 to $60.88 Now $60.97 +1.67% ▲ +1.52% +2.00% vs SPY
  9. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $63.02 to $64.46 Now $60.97 −3.25% ▲ +2.29% +2.67% vs SPY
  10. Oct 16, 20264w ago Insider Cluster Neutral 3/10 Entry $61.53 to $62.92 Now $60.97 −0.91% ▲ +2.26% +1.92% vs SPY
Showing 10 of 29

US Market Status

Market Closed · Opens in 6h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 19, 2026